| Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children H Visscher, CJD Ross, SR Rassekh, A Barhdadi, MP Dubé, H Al-Saloos, ... Journal of clinical oncology 30 (13), 1422-1428, 2012 | 445 | 2012 |
| Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy CJD Ross, H Katzov-Eckert, MP Dubé, B Brooks, SR Rassekh, ... Nature genetics 41 (12), 1345-1349, 2009 | 365 | 2009 |
| Efflux and Atherosclerosis: The Clinical and Biochemical Impact of Variations in the ABCA1 Gene RR Singaraja, LR Brunham, H Visscher, JJP Kastelein, MR Hayden Arteriosclerosis, thrombosis, and vascular biology 23 (8), 1322-1332, 2003 | 363 | 2003 |
| CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup SC Warby, A Montpetit, AR Hayden, JB Carroll, SL Butland, H Visscher, ... The American Journal of Human Genetics 84 (3), 351-366, 2009 | 297 | 2009 |
| A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer F Aminkeng, AP Bhavsar, H Visscher, SR Rassekh, Y Li, JW Lee, ... Nature genetics 47 (9), 1079-1084, 2015 | 271 | 2015 |
| Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin LR Brunham, PJ Lansberg, L Zhang, F Miao, C Carter, GK Hovingh, ... The pharmacogenomics journal 12 (3), 233-237, 2012 | 232 | 2012 |
| Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline‐induced cardiotoxicity in children H Visscher, CJD Ross, SR Rassekh, GSS Sandor, HN Caron, ... Pediatric blood & cancer 60 (8), 1375-1381, 2013 | 210 | 2013 |
| HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia SC Warby, H Visscher, JA Collins, CN Doty, C Carter, SL Butland, ... European Journal of Human Genetics 19 (5), 561-566, 2011 | 205 | 2011 |
| Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin‐Induced Hearing Loss in Children K Pussegoda, CJ Ross, H Visscher, M Yazdanpanah, B Brooks, ... Clinical Pharmacology & Therapeutics 94 (2), 243-251, 2013 | 141 | 2013 |
| Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome PJA de Pagter, R Schuurman, H Visscher, M de Vos, M Bierings, ... Biology of Blood and Marrow Transplantation 14 (7), 831-839, 2008 | 136 | 2008 |
| Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1 CL Wellington, LR Brunham, S Zhou, H Visscher, A Gelfer, C Ross, ... Journal of lipid research 44 (8), 1470-1480, 2003 | 135 | 2003 |
| Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro RR Singaraja, H Visscher, ER James, A Chroni, JM Coutinho, ... Circulation research 99 (4), 389-397, 2006 | 130 | 2006 |
| Genetic Variants in SLC22A17 and SLC22A7 are Associated With Anthracycline-Induced Cardiotoxicity in Children H Visscher, SR Rassekh, GS Sandor, HN Caron, EC Van Dalen, ... Pharmacogenomics 16 (10), 1065-1076, 2015 | 120 | 2015 |
| The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology CJD Ross, H Visscher, J Sistonen, LR Brunham, K Pussegoda, TT Loo, ... Thyroid 20 (7), 681-687, 2010 | 88 | 2010 |
| Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ... Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019 | 70 | 2019 |
| Pharmacogenomics of serious adverse drug reactions in pediatric oncology CJ Ross, H Visscher, SR Rassekh, LI Castro-Pastrana, E Shereck, ... J Popul Ther Clin Pharmacol 18 (1), 134-51, 2011 | 51 | 2011 |
| Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia L Dekker, FG Calkoen, Y Jiang, H Blok, SR Veldkamp, C De Koning, ... Blood advances 6 (7), 1969-1976, 2022 | 49 | 2022 |
| The influence of genetic variation on late toxicities in childhood cancer survivors: A review E Clemens, ALF van der Kooi, L Broer, E van Dulmen-den Broeder, ... Critical Reviews in Oncology/Hematology 126, 154-167, 2018 | 45 | 2018 |
| Alternate transcripts expressed in response to diet reflect tissue-specific regulation of ABCA1 ER James, J Crim, H Visscher, A Chatterjee, MR Hayden Journal of lipid research 46 (10), 2061-2071, 2005 | 34 | 2005 |
| Application of principal component analysis to pharmacogenomic studies in Canada H Visscher, CJD Ross, MP Dube, AMK Brown, MS Phillips, BC Carleton, ... The pharmacogenomics journal 9 (6), 362-372, 2009 | 33 | 2009 |
